Applied Nutrition Plc (LON:APN)

London · Delayed Price · Currency is GBP · Price in GBX

215.00

-4.00 (-1.83%)

Apr 28, 2026, 5:07 PM GMT

86.96% (1Y)

Market Cap	537.50M
Revenue (ttm)	134.00M
Net Income (ttm)	27.60M
Shares Out	250.00M
EPS (ttm)	0.11
PE Ratio	19.47
Forward PE	17.89
Dividend	n/a
Ex-Dividend Date	n/a

Volume	369,057
Average Volume	1,826,154
Open	216.00
Previous Close	219.00
Day's Range	215.00 - 225.50
52-Week Range	114.00 - 261.00
Beta	n/a
RSI	43.18
Earnings Date	Jun 19, 2026

About Applied Nutrition

Applied Nutrition Plc engages in the manufacture, wholesale, and retail of sports nutritional products in the United Kingdom and internationally. It offers whey protein, whey protein isolate, casein protein powder, clear protein, vegan protein, protein bars and oats, protein shakes and cans, and beef protein; BCAA powders and tablets, BCAA cans, creatine, aminos, and energy gels and drinks; pre-workout drinks, powders, and gels; and hydration and vitamin water, hydration tablets, hydration electrolyte and vitamin powder, and energy shots, as we... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 2014

Employees 270

Stock Exchange London Stock Exchange

Ticker Symbol APN

Full Company Profile

Financial Performance

In fiscal year 2025, Applied Nutrition's revenue was 107.10 million, an increase of 24.25% compared to the previous year's 86.20 million. Earnings were 21.10 million, an increase of 12.83%.

Financial Statements

News

Applied Nutrition Earnings Call Transcript: H1 2026

Revenue grew 57% year-over-year to GBP 74.5 million, with adjusted EBITDA up 56% and margin stable at 28.9%. FY 2026 guidance was raised to GBP 140 million, supported by strong product innovation, global expansion, and resilient market demand.

5 weeks ago - Transcripts

Applied Nutrition Earnings Call Transcript: H2 2025

FY 2025 saw 24% revenue growth, strong profitability, and global expansion, with momentum continuing into FY 2026. Investments in capacity and innovation support further growth, while risks around space and input costs are being actively managed.

6 months ago - Transcripts

Applied Nutrition Earnings Call Transcript: H1 2025

Revenue grew 19% year-over-year, exceeding guidance, with strong U.K. and European growth and robust D2C expansion. New partnerships and product launches underpin confidence in meeting GBP 100 million full-year revenue guidance, with margins and cash flow in line with expectations.

1 year ago - Transcripts